Authors: Nijman, HW van Diest, PJ Poort-Keesom, RJJ von Mensdorff-Pouilly, S Verstraeten, RA Kummer, A Meijer, CJLM Melief, CJM Hilgers, J Kenemans, P

Citation: Hw. Nijman et al., T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancer, EUR J OB GY, 94(1), 2001, pp. 114-120

Authors: Koelman, CA Coumans, ABC Nijman, HW Doxiadis, IIN Dekker, GA Claas, FHJ

Citation: Ca. Koelman et al., Correlation between oral sex and a low incidence of preeclampsia: a role for soluble HLA in seminal fluid?, J REPRO IMM, 46(2), 2000, pp. 155-166

Authors: Snijdewint, FGM von Mensdorff-Pouilly, S Karuntu-Wanamarta, AH Verstraeten, AA van Zanten-Przybysz, I Hummel, P Nijman, HW Kenemans, P Hilgers, J

Citation: Fgm. Snijdewint et al., Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls, CANCER IMMU, 48(1), 1999, pp. 47-55

Authors: Nijman, HW Kenemans, P Poort-Keesom, RJJ Verstraeten, RA Mensdorff-Pouilly, S Verheijen, RHM Melief, CJM Hilgers, J Meijer, CJLM

Citation: Hw. Nijman et al., Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancer, EUR J OB GY, 83(2), 1999, pp. 201-206

Authors: Offringa, R Toes, REM Ressing, ME Vierboom, MPM Ossendorp, F Van der Burg, SH Nijman, HW Kast, WM Melief, CJM

Citation: R. Offringa et al., Antitumor vaccination using peptide-based vaccines, RESEARCH IN, 1998, pp. 205-215